ROM icon

ProShares Ultra Technology

67.97 USD
-2.14
3.05%
At close Jun 13, 4:00 PM EDT
1 day
-3.05%
5 days
-0.40%
1 month
4.97%
3 months
25.54%
6 months
-7.96%
Year to date
-1.86%
1 year
-3.64%
5 years
214.09%
10 years
1,267.61%
0
Funds holding %
of 7,296 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

172% more call options, than puts

Call options by funds: $305K | Put options by funds: $112K

1.5% more ownership

Funds ownership: 6.1% [Q4 2024] → 7.6% (+1.5%) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

8% less capital invested

Capital invested by funds: $44.7M [Q4 2024] → $41.3M (-$3.35M) [Q1 2025]

18% less funds holding

Funds holding: 57 [Q4 2024] → 47 (-10) [Q1 2025]

69% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 13

Research analyst outlook

We haven’t received any recent analyst ratings for ROM.

Financial journalist opinion

Negative
Seeking Alpha
3 months ago
ROM: De-Risking Means De-Leveraging In Today's Environment
The market has shifted from consistent gains to increased volatility, signaling a potentially turbulent 2025, driven by factors like tariff news and economic uncertainty. Investors should proactively "de-risk" their portfolios by reducing leverage and high-beta investments, rather than reacting with "panic de-risking" during market downturns. The ProShares Ultra Technology ETF, a 2x leveraged technology fund, amplifies both gains and losses, making it particularly risky in a volatile market.
ROM: De-Risking Means De-Leveraging In Today's Environment
Neutral
Business Wire
6 months ago
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement
MONTPELLIER, France--(BUSINESS WIRE)--Analysis of a major subgroup of patients undergoing a first Total Knee Replacement (TKR), representing over 70% of the trial population (108 out of 151), revealed the following benefits when comparing patients treated with F14/mdc-CWM (n=51) to those in the control group (n=57)1: 70% reduction in the number of opioid users at 3 months post-surgery, 28% reduction in the total quantity of opioids consumed during the first 3 months post-surgery, Lower daily kn.
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement
Positive
Seeking Alpha
1 year ago
November Technology Dashboard, And The Risks Of ROM
Technology is the most overvalued sector, but the electronic equipment industry is undervalued relative to 11-year averages. 8 technology stocks were cheaper than their peers in November. ProShares Ultra Technology ETF: why the leveraged tech ROM ETF is risky.
Charts implemented using Lightweight Charts™